Skip to main content
. 2015 Jul 30;10:155. doi: 10.1186/s13014-015-0470-0

Fig. 1.

Fig. 1

Five-year PCSM among patients with T4 (a), N1 (b), or M1 (c) prostate cancer at diagnosis and conditioned on 5, 10, or 15 years of survival